Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891328 · ClinicalTrials.gov registry record
Experience With a Pediatric Summer Intensive Therapy Program
A clinical trial of Neurodevelopmental Disorders, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT04891328: Completed study of Neurodevelopmental Disorders, sponsored by University of Missouri-Columbia.
NCT04891328 is a study of Neurodevelopmental Disorders that has completed, run by University of Missouri-Columbia. The registered enrollment target is 13 participants, below the 581-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891328, a study of Neurodevelopmental Disorders, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.
Primary Outcome
Upon completion of the program, children and caregivers will participate in an interview about their experience
Conditions Studied
Interventions
- OTHER Intensive therapy program
Study Locations (1)
Missouri
- University of Missouri Healthcare Children's Therapy Center - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-05-24 |
| Est. Completion | 2021-10-01 |
What the finished NCT04891328 record still lists
NCT04891328 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 581-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Neurodevelopmental Disorders appearing as the primary indexed condition, and to 1 intervention - of which Intensive therapy program is the first listed.
NCT04891328 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04891328 about?
NCT04891328 is a clinical study titled "Experience With a Pediatric Summer Intensive Therapy Program". The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effect...
What is the current status of trial NCT04891328?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2021-05-24. Estimated completion is 2021-10-01.
What conditions does trial NCT04891328 study?
This clinical trial studies the following conditions: Neurodevelopmental Disorders.
What interventions are being tested in trial NCT04891328?
The interventions under investigation include: Intensive therapy program (OTHER).
Who is sponsoring clinical trial NCT04891328?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04891328 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurodevelopmental Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04891328's enrollment target sits among peer trials
13 28th of 27 the lowest of 27 other Neurodevelopmental Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurodevelopmental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Motor-voice Assessment in Infants (MAMI)
RECRUITING
-
Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder
RECRUITING
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI